Keenova Therapeutics plc Inventory Write-down
Keenova Therapeutics plc reported Inventory Write-down of $5.80 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:InventoryWriteDown · last filed 2026-08-11
- Keenova Therapeutics plc inventory write-down for the quarter ending 2026-06-30 was $1.70M, a 73.02% decline year-over-year.
- Keenova Therapeutics plc inventory write-down for the quarter ending 2026-03-31 was $4.10M, a 57.69% increase year-over-year.
- Keenova Therapeutics plc inventory write-down for the quarter ending 2025-12-31 was $3.70M.
- Keenova Therapeutics plc inventory write-down for the quarter ending 2025-09-26 was $18.70M.
- Keenova Therapeutics plc inventory write-down for fiscal 2025 was $31.30M, a 268.24% increase from fiscal 2024.
- Keenova Therapeutics plc inventory write-down for fiscal 2024 was $8.50M.
- Keenova Therapeutics plc inventory write-down for fiscal 2021 was $11.50M, a 37.84% decline from fiscal 2020.
- Keenova Therapeutics plc inventory write-down for fiscal 2020 was $18.50M, a 2.78% increase from fiscal 2019.
| Period end | Inventory Write-down 1 month | Inventory Write-down 3 month | Inventory Write-down 6 month | Inventory Write-down 9 month | Inventory Write-down 10 month | Inventory Write-down 10 month as first filed | Inventory Write-down 12 month |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | $1.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | $5.80M 10-Q · filed 2026-08-11 | $9.50M derived: sum of 3 quarters · filed 2026-08-11 | $28.20M derived: sum of 4 quarters · filed 2026-08-11 | |||
| 2026-03-31 | $4.10M 10-Q · filed 2026-05-12 | $7.80M derived: sum of 2 quarters · filed 2026-05-12 | $26.50M derived: sum of 3 quarters · filed 2026-05-12 | $32.80M derived: sum of 4 quarters · filed 2026-08-11 | |||
| 2025-12-31 | $3.70M derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-15 | $22.40M derived: sum of 2 quarters · filed 2026-04-15 | $28.70M derived: sum of 3 quarters · filed 2026-08-11 | $31.30M 10-K · filed 2026-04-15 | |||
| 2025-09-26 | $18.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $25.00M derived: sum of 2 quarters · filed 2026-08-11 | $27.60M 10-Q · filed 2025-11-10 | $19.10M derived: sum of 4 quarters · filed 2026-08-11 | |||
| 2025-06-27 | $6.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | $8.90M 10-Q · filed 2026-08-11 | $400.00K derived: sum of 3 quarters · filed 2026-08-11 | ||||
| 2025-03-28 | $2.60M 10-Q · filed 2026-05-12 | -$5.90M derived: sum of 2 quarters · filed 2026-05-12 | |||||
| 2024-12-27 | -$8.50M derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-15 | $8.50M 10-K · filed 2026-04-15 | |||||
| 2024-09-27 | $17.00M 10-Q · filed 2025-11-10 | ||||||
| 2023-12-29 | $2.40M 10-K · filed 2026-04-15 | ||||||
| 2023-11-14 | $9.60M 10-K · filed 2026-04-15 | $44.00M 10-K · filed 2024-03-26 | |||||
| 2021-12-31 | $11.50M 10-K · filed 2022-03-15 | ||||||
| 2020-12-25 | $18.50M 10-K · filed 2022-03-15 | ||||||
| 2019-12-27 | $18.00M 10-K · filed 2022-03-15 | ||||||
| 2018-12-28 | $37.90M 10-K · filed 2021-03-10 | ||||||
| 2017-12-29 | $34.10M 10-K · filed 2020-02-26 | ||||||
| 2016-12-30 | $8.50M 10-K · filed 2019-02-26 | ||||||
| 2016-09-30 | $29.20M 10-K · filed 2019-02-26 | ||||||
| 2015-12-25 | $1.20M 10-K · filed 2019-02-26 | ||||||
| 2015-09-25 | $0.00 10-K · filed 2018-02-27 | ||||||
| 2014-09-26 | $32.10M 10-K · filed 2016-11-29 | ||||||
| 2013-09-27 | $15.50M 10-K · filed 2015-11-24 | ||||||
| 2012-09-28 | $2.70M 8-K · filed 2015-04-03 |